Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
In Brief

Sylvester establishes Neuroendocrine Tumors Program; Aman Chauhan named leader

Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine established a dedicated Neuroendocrine Tumors Program and named Aman Chauhan as leader. 
March 17, 2023
Vol.49 No.11
In Brief

Jaime Merchán named co-leader of Translational and Clinical Oncology Research Program at Sylvester

Jaime Merchán was named co-leader of the Translational and Clinical Oncology Research Program at Sylvester Comprehensive Cancer Center, part of UHealth—University of Miami Health System.
February 24, 2023
Vol.49 No.08
In Brief

Sylvester researchers receives $1.4M from Florida DoH to help construction workers quit smoking

The Florida Department of Health granted more than $1.4 million from the James and Esther King Biomedical Research Program to Taghrid Asfar, a researcher at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, to help construction workers quit smoking.
February 24, 2023
Vol.49 No.08
In Brief

Priyamvada Rai named co-leader of the Tumor Biology Research Program at Sylvester

Priyamvada Rai was named co-leader of the Tumor Biology Research Program at Sylvester Comprehensive Cancer Center, part of UHealth—University of Miami Health System.
February 24, 2023
Vol.49 No.08
In Brief

Priyamvada Rai to co-lead Sylvester’s Tumor Biology Research Program

Priyamvada Rai was named Tumor Biology Research Program co-leader at Sylvester Comprehensive Cancer Center, part of UHealth—University of Miami Health System.
February 10, 2023
Vol.49 No.06
Clinical Roundup

Sylvester scientists develop AI to gain insight into glioblastoma

Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, collaborating with international researchers, have developed an AI algorithm that performs advanced computational analysis to identify potential therapeutic targets for glioblastoma multiforme and other cancers.
February 03, 2023
Vol.49 No.05
In Brief

Sylvester, Emory researchers receive $3.3M NIH grant to study sMRI

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and Emory University will share a five-year, $3.3 million NIH grant to study spectroscopic MRI and make it easier to use. 
January 27, 2023
Vol.49 No.04
Clinical Roundup

Sylvester study addresses one of the major mechanisms of pancreatic cancer treatment resistance

Investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown for the first time that a combination of targeted therapies with immunotherapy addresses a major cause of treatment resistance in pancreatic cancer.
January 27, 2023
Vol.49 No.04
In Brief

Rhonda Curry named chief marketing and communications officer at Sylvester

Rhonda Curry was named chief marketing and communications officer at Sylvester Comprehensive Cancer Center, part of UHealth—University of Miami Health System.
January 13, 2023
Vol.49 No.02
In Brief

Sylvester to build myeloma research institute

Sylvester Comprehensive Cancer Center is building a dedicated Myeloma Research Institute. C. Ola Landgren, who joined Sylvester two years ago, will be the director.
December 09, 2022
Vol.48 No.44

Posts navigation

Previous12345Next

Trending Stories

  • Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
  • ACOG says it will no longer accept federal funding
  • Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
    Brian Druker returns to executive role as president of the new Knight Cancer Group
  • When public service ends abruptly, do books provide solace? An escape? Perspective?
    Former NIH and FDA employees tell us what they are reading in 2025
  • Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
    Her collection, “To See Yourself As You Vanish,” will be published three years after her death
  • The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
    Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2025 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation
Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account